CD44 and ovarian cancer: Moreover, inhibition of autophagy through ATG5 knockdown resulted in a decrease in the CD44 + CD117+ cell proportion, concurrently diminishing both the chemoresistance and tumorigenic potential of ovarian cancer stem cells [41].